Diamond Hill Capital Management
ASTH icon

Diamond Hill Capital Management’s Astrana Health ASTH Stock Holding History

Diamond Hill Capital Management’s Portfolio ASTH Stock Details ASTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$19.9M Buy
559,169
+83,228
+17% +$3.28M 0.22% 84
2026
Q2 		$22.1M Sell
475,941
-68,093
-13% -$2.45M 0.18% 102
2026
Q1 		$13.3M Buy
544,034
+111,308
+26% +$2.64M 0.08% 120
2025
Q4 		$10.7M Buy
432,726
+71,462
+20% +$1.9M 0.06% 127
2025
Q3 		$10.2M Buy
361,264
+89,733
+33% +$2.43M 0.05% 127
2025
Q2 		$6.76M Buy
271,531
+60,493
+29% +$1.7M 0.03% 133
2025
Q1 		$6.54M Buy
211,038
+51,827
+33% +$1.73M 0.03% 127
2024
Q4 		$5.02M Buy
159,211
+16,911
+12% +$803K 0.02% 137
2024
Q3 		$8.24M Buy
142,300
+38,826
+38% +$1.91M 0.03% 129
2024
Q2 		$4.2M Buy
+103,474
New +$4.1M 0.02% 140

Other funds holding ASTH

BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return
SteelPeak Wealth
SteelPeak Wealth Woodland Hills, California $4.07B AUM 38.25% 1-Year Est. Return
Royce & Associates
Royce & Associates New York $11B AUM 39.4% 1-Year Est. Return

Diamond Hill Capital Management's ASTH Position: Q3 2026 in Review

Diamond Hill Capital Management increased its Astrana Health (ASTH) stake by 17% in Q3 2026, buying an estimated $3.28M and bringing the position to 559,169 shares worth $19.9M. The position accounts for 0.22% of the portfolio, ranked #84.

Diamond Hill Capital Management first reported a position in ASTH in Q2 2024 and has held it in 10 quarters since. The position peaked at $22.1M in Q2 2026. 173 funds tracked by Wall St. Rank hold ASTH as of Q3 2026.

  • Diamond Hill Capital Management held 559,169 shares of Astrana Health worth $19.9M as of Q3 2026.
  • Diamond Hill Capital Management bought 83,228 Astrana Health shares in Q3 2026, an estimated $3.28M.
  • Astrana Health made up 0.22% of Diamond Hill Capital Management's portfolio in Q3 2026, its #84 holding.
  • Diamond Hill Capital Management first reported a position in Astrana Health in Q2 2024 and has held it in 10 quarters since.
  • Diamond Hill Capital Management's Astrana Health position peaked at $22.1M in Q2 2026.
  • 173 funds tracked by Wall St. Rank held Astrana Health as of Q3 2026.

Based on Diamond Hill Capital Management's 13F filing for Q3 2026, filed 10 Nov 2026.